APP and Alzheimer disease: The molecular mechanism that involves alteration of Ca2+ homeostasis with AD is still far from clear, however, mainly due to the lack of a model system that recapitulates Ca2+ dysregulation in neurodegeneration in the absence of mutations in PSEN1, PSEN2, and APP, as occurs in late-onset AD.